Related Experiment Video
Updated: Mar 14, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Anti-PD1-Induced Pneumonitis: Capturing the Hidden Enemy
1Drug Development Department, Gustave Roussy Comprehensive Cancer Center, Villejuif, France. EDUARDO.CASTANON-ALVAREZ@gustaveroussy.fr.
Abstract:
Anti-PD1 antibodies have led to a therapeutic shift in cancer treatment. Although classically described as "well tolerated," these drugs can lead to severe immune-related adverse events. Using CT scan imaging, Nishino and colleagues describe different radiologic patterns and their possible relation to severity of several cases of anti-PD1-induced pneumonitis. Clin Cancer Res; 22(24); 5956-8. ©2016 AACRSee related article by Nishino et al., p. 6051.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia III: Complications and Assessment
Pneumothorax-II
Clinical Manifestations:

